$3.13
-0.07-2.19%
At close: -
$3.17
0.041.28%
After Hours: 4:02 PM EDT
Comments
Loading...
Arbutus Biopharma Insider Trading Activity | NASDAQ:ABUS | Benzinga
Track the latest Arbutus Biopharma insider trading activity. Stay informed on recent buys, sells, and market impact for Arbutus Biopharma stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Arbutus Biopharma Corp Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for Arbutus Biopharma Corp
Shares Outstanding
191.527M
Insider Shares Owned
7.071M
Insider Percentage Owned
3.92%
Institutional Shares Held
52.402M
Institutional Percentage Held
27.4%
| Feb 05, 2025 | David C Hastings | CHIEF FINANCIAL OFFICER | -22.18K | $3.28 | -$72.83K | SELL | -12.19% | 159.72K | Feb 04 | View |
| Feb 05, 2025 | Karen Sims | CHIEF MEDICAL OFFICER | -19.35K | $3.28 | -$63.52K | SELL | -15.41% | 106.19K | Feb 04 | View |
| Feb 05, 2025 | Michael J McElhaugh | INTERIM PRESIDENT & CEO | -23.79K | $3.28 | -$78.10K | SELL | -1.58% | 1.48M | Feb 04 | View |
| Feb 05, 2025 | J. Christopher Naftzger | GENERAL COUNSEL AND CCO | -11.33K | $3.28 | -$37.21K | SELL | -11.61% | 86.24K | Feb 04 | View |
| Aug 16, 2024 | Keith S Manchester | DIRECTOR | 46.07K | $2.12 | -$1.88K | SELL-OPTIONS | ∞ | 46.07K | Aug 14 | View |
| Feb 05, 2024 | Karen Sims | CHIEF MEDICAL OFFICER | 96.64K | $2.31 | -$10.08K | GRANT | 334.40% | 125.54K | Feb 01 - Feb 02 | View |
| Feb 05, 2024 | David C Hastings | CHIEF FINANCIAL OFFICER | 102.91K | $2.31 | -$22.18K | GRANT | 130.26% | 181.91K | Feb 01 - Feb 02 | View |
| Feb 05, 2024 | Michael J Sofia | CHIEF SCIENTIFIC OFFICER | 99.52K | $2.31 | -$23.08K | GRANT | 6.41% | 1.65M | Feb 01 - Feb 02 | View |
| Feb 05, 2024 | Michael J McElhaugh | INTERIM PRESIDENT & CEO | 113.64K | $2.31 | -$23.50K | GRANT | 8.17% | 1.50M | Feb 01 - Feb 02 | View |
| Dec 03, 2021 | Michael J Sofia | CHIEF SCIENTIFIC OFFICER | -200.00K | $5.09 | -$1.02M | SELL | -11.97% | 1.47M | Dec 01 | View |
| Feb 10, 2021 | Michael J McElhaugh | CHIEF BUSINESS OFFICER | -20.00K | $5.00 | -$100.00K | SELL | -1.51% | 1.31M | Feb 09 | View |
| Dec 16, 2020 | Michael J McElhaugh | — | -40.00K | $5.00 | -$200.03K | SELL | -2.93% | 1.33M | Dec 14 | View |
| Jul 27, 2020 | Michael J McElhaugh | — | -20.00K | $5.01 | -$100.20K | SELL | -1.44% | 1.37M | Jul 23 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
ABUS Insider Trading News
No news found
